T1	Concept 37 42	males
T2	Action 48 56	infected
T3	Concept 60 92	Middle East respiratory syndrome
T4	Concept 93 103	(MERS)-CoV
T5	Concept 108 116	SARS-CoV
T6	Concept 32 36	more
R1	subject Arg1:T2 Arg2:T3	
R2	subject Arg1:T2 Arg2:T5	
R3	target Arg1:T2 Arg2:T1	
R4	in-context Arg1:T2 Arg2:T6	
*	same-as T3 T4
T7	Concept 131 137	emdoin
T8	Action 138 147	inhibited
T9	Concept 168 178	3a protein
T10	Concept 148 156	SARS-CoV
R5	subject Arg1:T8 Arg2:T7	
R6	target Arg1:T8 Arg2:T9	
R7	in-context Arg1:T9 Arg2:T10	
T11	Action 185 192	blocked
T12	Concept 220 242	SARS-CoV spike protein
T13	Concept 247 251	ACE2
T14	Concept 196 207	interaction
R8	target Arg1:T11 Arg2:T14	
R11	subject Arg1:T11 Arg2:T7	
R12	in-context Arg1:T14 Arg2:T12	
R13	in-context Arg1:T14 Arg2:T13	
T15	Concept 372 381	spreading
T16	Concept 385 393	Covid-19
R9	in-context Arg1:T15 Arg2:T16	
T17	Concept 366 371	rapid
R10	has-property Arg1:T15 Arg2:T17	
T18	Concept 256 272	transmissibility
T19	Concept 277 283	higher
R14	has-property Arg1:T18 Arg2:T19	
T20	Concept 302 310	SARS-CoV
T21	Concept 314 318	2003
R15	in-context Arg1:T19 Arg2:T20	
R16	in-time Arg1:T19 Arg2:T21	
R17	causes Arg1:T15 Arg2:T18	
T23	Concept 414 438	SARS-CoV S-RBD structure
T22	Concept 444 452	template
T28	Concept 476 516	high-resolution homology modeling method
R18	in-context Arg1:T23 Arg2:T22	
T24	Action 472 475	use
R19	subject Arg1:T24 Arg2:T28	
T25	Concept 520 530	accurately
T26	Action 531 538	predict
T27	Concept 543 551	3D model
R20	causes Arg1:T23 Arg2:T24	
R21	target Arg1:T24 Arg2:T26	
R22	target Arg1:T26 Arg2:T27	
R23	has-property Arg1:T26 Arg2:T25	
T31	Concept 633 653	antigen distribution
T29	Concept 673 677	Muc4
T30	Concept 684 686	WT
T32	Concept 702 708	airway
T33	Concept 712 736	106 parenchymal staining
T34	Action 659 664	noted
T35	Concept 618 629	differences
T36	Concept 606 617	significant
A1	Negated T36
R24	has-property Arg1:T35 Arg2:T36	
R26	subject Arg1:T34 Arg2:T35	
R27	target Arg1:T34 Arg2:T29	
R28	target Arg1:T34 Arg2:T30	
R29	in-place Arg1:T34 Arg2:T32	
T37	Action 557 566	examining
T40	Concept 567 592	SARS-CoV antigen staining
R31	in-context Arg1:T34 Arg2:T37	
R34	target Arg1:T37 Arg2:T40	
R30	in-place Arg1:T34 Arg2:T33	
R32	in-place Arg1:T34 Arg2:T31	
